Molecular Partners AG (XSWX:MOLN) Effective Interest Rate on Debt % : 0.83% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Molecular Partners AG Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Molecular Partners AG's annualized positive value of Interest Expense for the quarter that ended in Sep. 2024 was CHF0.02 Mil. Molecular Partners AG's average total debt for the quarter that ended in Sep. 2024 was CHF2.90 Mil. Therefore, Molecular Partners AG's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 was 0.83%.

Molecular Partners AG Effective Interest Rate on Debt % Historical Data

The historical data trend for Molecular Partners AG's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Effective Interest Rate on Debt % Chart

Molecular Partners AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

3.58

6.04

8.27

11.11

0.80

Molecular Partners AG Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															0.78	0.84	0.80	0.75	0.83

Competitive Comparison of Molecular Partners AG's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Molecular Partners AG's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Molecular Partners AG's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Partners AG's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Molecular Partners AG's Effective Interest Rate on Debt % falls into.

Molecular Partners AG Effective Interest Rate on Debt % Calculation

Molecular Partners AG's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * -0.034	/	( (4.85	+	3.652)	/ 2 )
=	-1 * -0.034	/	4.251
=	0.80 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	3.652	+	1.198
=	4.85

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	2.444	+	1.208
=	3.652

Molecular Partners AG's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2024 )	+	Total Debt (Q: Sep. 2024 ))	/ count )
=	-1 * -0.024	/	( (3.049	+	2.747)	/ 2 )
=	-1 * -0.024	/	2.898
=	0.83 %

where

	Total Debt (Q: Jun. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	1.837	+	1.212
=	3.049

	Total Debt (Q: Sep. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	1.532	+	1.215
=	2.747

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Molecular Partners AG (XSWX:MOLN) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Molecular Partners AG Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Molecular Partners AG's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Molecular Partners AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (XSWX:MOLN) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

MOLN:USA MLLCF:USA MOLNz:UK 0QXX:UK

Address

Wagistrasse 14, Schlieren, Zurich, CHE, 8952

Website

https://www.molecularpartners.com

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.